Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Allarity Therapeutics, Inc. (ALLR) is a Biotechnology company based in US with a market capitalization of $18.9M. Free cash flow was negative at -$14.8M. This page tracks ALLR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 6 employees · IPO Dec 21, 2021
Valuation
Valuation & price
$1.35as of May 17, 2026· -31.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.93
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$18.9M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$14.8M
Free cash flow (USD)
-$13.3M
Net debt
Net cash position
794.8%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.17)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 1, 2026Filing
Annual Meeting Results
- 8-K eventJun 22, 2026Filing
Trial Presentation Announcement
- 8-K eventJun 2, 2026Filing
Management Services Agreement
- Quarterly reportMay 15, 2026Filing
10-Q Filed
- 8-K eventMay 8, 2026Filing
Company Presentation
- 8-K eventMay 6, 2026Filing
Manufacturing Campaign Update
- 8-K eventApr 28, 2026Filing
Patent Notice of Allowance
- FinancingApr 24, 2026Filing
Securities Registration
- 8-K eventApr 22, 2026Filing
Scientific Posters Presented
- 8-K eventApr 1, 2026Filing
Earnings Release
Questions
Frequently asked questions
What is Allarity Therapeutics, Inc.'s market cap?
Allarity Therapeutics, Inc. (ALLR) has a market capitalization of $18.9M.
What is ALLR's P/E ratio?
A meaningful P/E ratio is not available for ALLR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ALLR's price-to-book (P/B) ratio?
ALLR trades at 1.93 times book value per share.
When did Allarity Therapeutics, Inc. last report earnings?
ALLR last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying ALLR stock?
SEC Form 4 filings show no open-market insider buys at Allarity Therapeutics, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.